UroGen Pharma Ltd. URGN

Set alert

24.75 USD -0.98 (-3.81%)

At closeNov 6, 2026, 5:53 PM EST

24.00 -0.75 -3.03%

After hours · Nov 6, 5:53 PM ET

24.40 Day range 26.34

16.50 52-week range 50.81

Held by insiders 3.48%

Held by institutions 97.87%

Float held by institutions 101.40%

Institutions 274

Top institutional holders
Holder	% held	Shares	Value	Reported
RTW Investments LP	9.26%	4,543,895	112.46M	Jun 29, 2026
Blackrock Inc.	6.53%	3,201,461	79.24M	Jun 29, 2026
Morgan Stanley	5.25%	2,576,363	63.76M	Jun 29, 2026
Kynam Capital Management, LP	4.96%	2,434,207	60.25M	Jun 29, 2026
Jefferies Financial Group Inc.	4.48%	2,199,652	54.44M	Sep 29, 2026
SG Americas Securities, LLC	4.19%	2,052,906	50.81M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
iShares Trust-iShares Russell 2000 ETF	2.25%	1,103,214	27.30M	Sep 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund	1.78%	874,981	21.66M	Sep 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.95%	466,099	11.54M	Aug 30, 2026
iShares Trust-iShares Russell 2000 Growth ETF	0.70%	343,762	8.51M	Sep 29, 2026
iShares Trust-iShares Biotechnology ETF	0.66%	323,796	8.01M	Sep 29, 2026
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund	0.50%	244,145	6.04M	Aug 30, 2026

URGN insiders
Insider	Relation	Latest transaction	Date	Shares held
BUTITTA CYNTHIA M	Director	Conversion of Exercise of derivative security	Nov 25, 2025	2,000
DEGNAN CHRISTOPHER	Chief Financial Officer	Sale	Oct 7, 2025	2,280
HOLDEN STUART M.D.	Director	Conversion of Exercise of derivative security	Nov 25, 2025	2,000
ROBINSON JAMES A JR.	Director	Conversion of Exercise of derivative security	Aug 25, 2026	8,000
SCHOENBERG MARK	Officer	Sale	Sep 7, 2026	59,882
SMITH JASON DREW	General Counsel	Sale	Sep 7, 2026	53,141

Held by funds